Background: To evaluate the diagnostic accuracy of contrast-enhanced ultrasound (CEUS) in characterizing between malignant and benign renal lesions confirmed by histological examination. Methods: Overall, 110 patients, for a total of 118 renal masses previously identified at CT and MRI underwent CEUS. An expert radiologist evaluated morphological, qualitative and quantitative parameters. Acquired data were analyzed to assess the value of each parameter to differentiate between malignant and benign lesions. Results: Histological results of 118 renal masses showed 88 (75%) malignant lesions and 30 (25%) benign lesions. Among morphological features, inhomogeneous echogenicity was the best predictor of malignancy depicting a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 76%, 76%, 88% and 57%, respectively. Among qualitative parameters, the most reliable parameter was the presence of pseudo-capsule. Here, sensitivity, specificity, positive PPV and NPV were 85%, 86%, 94% and 71%, respectively. Among quantitative parameters, the most reliable parameters were peak intensity (PI) and the area under the (AUC) with sensitivity, specificity, PPV and NPV values of 94%, 92%, 96% and 87% and 99%, 92%, 97% and 97%, respectively. Finally, the most reliable parameters were combined to distinguish between benign and malignant lesions. The best combination obtained was restricted to CEUS parameters (PI and AUC). Here, sensitivity, specificity, PPV, NPV and accuracy rate were 93%, 100%, 100%, 83% and 93%, respectively. Conclusions: CEUS increases the US accuracy to discriminate between benign and malignant renal lesions.
We present here two special cases of urolithiasis. The first one shows a giant bladder lithiasis resulting in severe renal insufficiency in a 63-year-old patient, who had previously had nicturia (2-3 times), occasional episodes of urinary frequency and burning micturition, in the absence of renal colic, hematuria or interrupted urination. The second case referes to an 85-year-old man suffering from prostatic enlargement and bladder stones, hospitalized to undergo intervention of trans-vesical prostatic adenomectomy, during which two star-shaped stones were found without obvious symptoms.
45di sigaretta, le terapie radianti, la balanite xerotica obliterante e la predisposizione genetica [1]. Inoltre c'è una forte evidenza che HPV16 e 18 siano associati all'insorgenza di tumore in oltre il 50% dei casi [2,3].In Europa e in America la fascia d'età più colpita è quella compresa fra 40 e 70 anni, con un massimo intorno a 55 anni. INTRODUZIONEFra le varie lesioni maligne del pene, quella di gran lunga più frequente è il carcinoma squamoso; tale neoplasia origina preferibilmente, in ordine decrescente di frequenza, in corrispondenza del glande, della superficie interna del prepuzio, del solco balano-prepuziale e, più raramente, del corpo del pene.Anche se i fattori cancerogeni precisi non sono stati individuati, è stato appurato che le persone circoncise precocemente risultano protette dall'insorgenza del carcinoma; è stato altresì riscontrato che l'incidenza aumenta nel caso di condizioni socio-economiche molto disagiate e, di conseguenza, anche di cattive condizioni igieniche. A conferma di ciò si noti il ruolo che viene riconosciuto alla fimosi e all'accumulo di smegma che ne consegue tra i fattori di rischio. Si ritiene che varie altre condizioni possano favorire l'insorgenza di tale patologia, come il fumo
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.